SpyBiotech, which makes a 'superglue' for vaccines, raises £4M from GV and Oxford

The startup bug has hit the world of biotechnology, and the latest victim is a business that is building a "super glue," coincidentally, for bug-combating vaccines. SpyBiotech -- a startup spun out of Oxford University that has developed a way to bond antigens to viruses and other particles to make vaccines -- has announced £4 million ($5 million) in funding.